Roden D M, Iansmith D H
Am J Med. 1987 Mar 20;82(3A):18-23. doi: 10.1016/0002-9343(87)90128-8.
Low potassium and magnesium concentrations not only cause cardiac arrhythmias, but also interfere with the efficacy or enhance the toxicity of drugs commonly used to treat patients with heart disease. Arrhythmias may develop in hypokalemia due to enhanced normal automaticity, abnormal automaticity, or slowed conduction; moreover, hypokalemia is associated with enhanced digitalis toxicity, quinidine-related Torsades de pointes, and interference with the antiarrhythmic activity of quinidine. Hypomagnesemia, especially in the presence of other electrolyte abnormalities, also affects automaticity and is associated with decreased efficacy of digitalis and with quinidine-related Torsades de pointes. Therefore, treatment that controls hypertension without causing electrolyte abnormalities is preferable for patients who are at risk of arrhythmias, or who are receiving drugs such as digitalis or quinidine.
低钾和低镁浓度不仅会导致心律失常,还会干扰常用于治疗心脏病患者的药物疗效或增强其毒性。低钾血症时,由于正常自律性增强、异常自律性或传导减慢,可能会发生心律失常;此外,低钾血症与洋地黄毒性增强、奎尼丁相关的尖端扭转型室速以及对奎尼丁抗心律失常活性的干扰有关。低镁血症,尤其是在存在其他电解质异常的情况下,也会影响自律性,并与洋地黄疗效降低和奎尼丁相关的尖端扭转型室速有关。因此,对于有发生心律失常风险或正在接受洋地黄或奎尼丁等药物治疗的患者,选择能控制高血压且不引起电解质异常的治疗方法更为可取。